FDA inspections are nobody’s idea of a good time. However,
proper planning is crucial not only for ensuring baseline compliance, but also
for establishing an effective corporate culture and building long-term company
value. In this edition of Consultants Corner, we spotlight advice from
Jamie Harris and Nancy Lincé, who discussed the issue onstage last month at the
MedTech Strategist Innovation Summit in Dublin.
